ArticleClinical and experimental medicine2025

Predicting the risk of ibrutinib in combination with R-ICE in patients with relapsed or refractory DLBCL using explainable machine learning algorithms.

Ni Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.